Korean drugmaker Dasan hit with FDA warning letter on testing, GMP standards
admin 4th October 2017 Uncategorised 0South Korean drugmaker Dasan E&T was handed an FDA warning letter based on an inspection earlier this year that found numerous testing and manufacturing issues at its plant.
More: Korean drugmaker Dasan hit with FDA warning letter on testing, GMP standards
Source: fierce